Inventor · disambiguated record
Arkady Mandel
Also filed as: MANDEL ARKADY
14 granted patents·35 pending applications·31 citations·filing 2001–2024
88Inventor score
Files withVASOGEN IRELAND LTD19THERALASE TECH INC11LYNCH MARINA A2THERALASE BIOTECH INC2BOLTON ANTHONY E1
Top patents by PatentIndex Score
49 records- 0191US9737565B2Metal-glycoprotein complexes and their use as chemotherapeutic compoundsTHERALASE TECH INC·Filed 2016·Granted Aug 22, 2017·8 cites·11 claims
- 0281US10335608B2Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnosticsTHERALASE TECH INC·Filed 2017·Granted Jul 2, 2019·2 cites·13 claims
- 0381US10111936B2Metal-glycoprotein complexes and photodynamic therapy of immune privileged sites with sameTHERALASE TECH INC·Filed 2016·Granted Oct 30, 2018·2 cites·17 claims
- 0473US7255880B2Treatment of endothelin-related disordersVASOGEN IRELAND LTD·Filed 2004·Granted Aug 14, 2007·4 cites·19 claims
- 0571US11241587B2Fiber optic light delivery, monitoring and apparatus thereforTHERALASE TECH INC·Filed 2016·Granted Feb 8, 2022·3 cites·19 claims
- 0670US7122208B2Compositions containing apoptotic entitiesVASOGEN IRELAND LTD·Filed 2002·Granted Oct 17, 2006·5 cites·28 claims
- 0768US6953591B2Apoptosis-mimicking synthetic entities and use thereof in medical treatmentVASOGEN IRELAND LTD·Filed 2001·Granted Oct 11, 2005·4 cites·10 claims
- 0865US2025375511A1Method for treating conditions associated with hyperproliferating cells comprising combined administration of infectious agents and metal cationsTHERALASE TECH INC·Filed 2024·Application pending·0 cites
- 0965US2025375458A1Compositions and methods to combat multidrug-resistant and persistent t-cell-mediated, oncological and infectious diseasesTHERALASE TECH INC·Filed 2024·Application pending·0 cites
- 1063US10525279B2Apparatus and method for multiwavelength photodynamic therapyTHERALASE TECH INC·Filed 2015·Granted Jan 7, 2020·1 cites·14 claims
- 1163US2025114456A1Enhanced immunotherapeutic method comprising combined administration of photodynamic / radiotherapeutic compounds and immunotherapeutic agentsTHERALASE TECH INC·Filed 2023·Application pending·0 cites
- 1262US7279156B2Apoptotic entities for use in treatment of endothelium dysfunction disordersVASOGEN IRELAND LTD·Filed 2001·Granted Oct 9, 2007·2 cites·14 claims
- 1361US7597906B2Apoptosis-mimicking synthetic entities and use thereof in medical treatmentVASOGEN IRELAND LTD·Filed 2007·Granted Oct 6, 2009·0 cites·5 claims
- 1459US2008166400A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1559US2008160074A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1659US2008171082A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1759US2008124386A1Apoptosis-mimicking synthetic entities and use thereof in medical treatmentVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 1859US2008171081A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesBOLTON ANTHONY ERNEST·Filed 2007·Application pending·0 cites
- 1958US2008075764A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 2055US2005037063A1Combined therapiesFiled 2004·Application pending·0 cites
- 2155US2008131416A1Apoptotic entities for use in treatment of neurodegenerative and other neurological disordersVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 2255US2005058698A1Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's DiseaseFiled 2004·Application pending·0 cites
- 2354US11793818B2Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapyTHERALASE TECH INC·Filed 2019·Granted Oct 24, 2023·0 cites·20 claims
- 2453US2007087010A1Apoptotic entities for use in treatment of neurodegenerative and other neurological disordersVASOGEN IRELAND LTD·Filed 2006·Application pending·0 cites
- 2552US11813330B2Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agentsTHERALASE TECH INC·Filed 2021·Granted Nov 14, 2023·0 cites·22 claims
- 2652US2006105031A1Accelerating recovery from traumaVASOGEN IRELAND LTD·Filed 2003·Application pending·0 cites
- 2752US2022280529A1Inactivation of pathogens using metal-based coordination complexes, and methods and compositions for treating and preventing microbial and/or viral infectionsTHERALASE TECH INC·Filed 2021·Application pending·0 cites
- 2851US2004013718A1Pharmaceutically acceptable phosphate-glycerol carrying bodiesFiled 2003·Application pending·0 cites
- 2951US2008063631A1Apoptotic entities for use in treatment of endothelium dysfunction disordersVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 3051US2003175334A1Phospholipid bodies and use thereof in medical treatmentFiled 2003·Application pending·0 cites
- 3150US2005147660A1Peptide-carrying bodies for immune responseFiled 2003·Application pending·0 cites
- 3249US2005058767A1Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entitiesFiled 2002·Application pending·0 cites
- 3347US7132285B2Apoptotic entities for use in treatment of neurodegenerative and other neurological disordersVASOGEN IRELAND LTD·Filed 2001·Granted Nov 7, 2006·0 cites·4 claims
- 3447US2004101517A1Blood brain barrier modulation using stressed autologous blood cellsFiled 2002·Application pending·0 cites
- 3546US2007238708A1Acute Inflammatory Condition TreatmentVASOGEN IRELAND LTD·Filed 2004·Application pending·0 cites
- 3644US2007071805A1Treatment of inflammation and vascular abnormalities of the eyeVASOGEN IRELAND LTD·Filed 2006·Application pending·0 cites
- 3743US2007298020A1Apoptotic entities for use in treatment of endothelium dysfunction disordersVASOGEN IRELAND LTD·Filed 2007·Application pending·0 cites
- 3842US2002090360A1Inflammatory cytokine secretion inhibitionFiled 2001·Application pending·0 cites
- 3942US2002090359A1Transforming growth factor regulationFiled 2001·Application pending·0 cites
- 4041US2006035809A1Apoptosis-mimicking natural vesicles and use thereof in medical treatmentBOLTON ANTHONY E·Filed 2002·Application pending·0 cites
- 4141US2008138432A1Acute Inflammatory Condition TreatmentVASOGEN IRELAND LTD·Filed 2005·Application pending·0 cites
- 4240US11464798B2Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using sameTHERALASE BIOTECH INC·Filed 2018·Granted Oct 11, 2022·0 cites·20 claims
- 4340US2005063995A1Compositions and methods for selected tumour treatmentFiled 2001·Application pending·0 cites
- 4439US2006008517A1Treatment of age-related memory impairmentLYNCH MARINA A·Filed 2004·Application pending·0 cites
- 4537US2004265927A1Apoptosis-mimicking synthetic entities and use thereof in medical treatmentFiled 2002·Application pending·0 cites
- 4635US2006105032A1Multiple sclerosis treatmentLYNCH MARINA A·Filed 2005·Application pending·0 cites
- 4733US2002051771A1Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disordersFiled 2001·Application pending·0 cites
- 4833US2002150560A1Treatment of Il-10 deficienciesFiled 2001·Application pending·0 cites
- 4933US2020094070A1Method and apparatus for photoactivating nuclear receptorsTHERALASE BIOTECH INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arkady Mandel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →